UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031155
Receipt number R000035584
Scientific Title Efficacy and feasibility of re-irradiation with CyberKnife radiosurgery and stereotactic radiotherapy as a salvage treatment for in-field neck lymph node recurrences after conventional radiotherapy: a retrospective study
Date of disclosure of the study information 2018/03/01
Last modified on 2019/12/25 09:37:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and feasibility of re-irradiation with CyberKnife radiosurgery and stereotactic radiotherapy as a salvage treatment for in-field neck lymph node recurrences after conventional radiotherapy: a retrospective study

Acronym

Efficacy and feasibility of re-irradiation with CyberKnife radiosurgery and stereotactic radiotherapy as a salvage treatment for in-field neck lymph node recurrences after conventional radiotherapy: a retrospective study

Scientific Title

Efficacy and feasibility of re-irradiation with CyberKnife radiosurgery and stereotactic radiotherapy as a salvage treatment for in-field neck lymph node recurrences after conventional radiotherapy: a retrospective study

Scientific Title:Acronym

Efficacy and feasibility of re-irradiation with CyberKnife radiosurgery and stereotactic radiotherapy as a salvage treatment for in-field neck lymph node recurrences after conventional radiotherapy: a retrospective study

Region

Japan


Condition

Condition

neck lymph node recurrences

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and toxicity of stereotactic radiotherapy using CyberKnife for in-field lymph node recurrences after radiotherapy, retrospectively.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of acute toxicities

Key secondary outcomes

One-year local control, incidence of late toxicities, and overall survival rates.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) diagnosed as recurrence from clinical course
2) evaluable lesions detected by CT or MRI
3) performance status 0 - 2
4) recurrence in the previous irradiation site

Key exclusion criteria

recurrences out-field radiotherapy

Target sample size

19


Research contact person

Name of lead principal investigator

1st name Hiro
Middle name
Last name Sato

Organization

Gunma University Graduate School of Medicine

Division name

Department of Radiation Oncology

Zip code

371-8511

Address

3-39-22 Showa-machi, Maebashi, Gunma 371-8511 JAPAN

TEL

027-220-8383

Email

h-sato0808@hotmail.co.jp


Public contact

Name of contact person

1st name Daijiro
Middle name
Last name Kobayashi

Organization

Kanto Neurosurgical Hospital

Division name

Cyber Center

Zip code

360-0804

Address

1120, Dai, Kumagaya, Saitama 360-0804 JAPAN

TEL

048-521-3133

Homepage URL


Email

m07201029@gmail.com


Sponsor or person

Institute

Kanto Neurosurgical Hospital

Institute

Department

Personal name



Funding Source

Organization

Kanto Neurosurgical Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanto Neurosurgical Hospital

Address

1120, Dai, Kumagaya, Saitama 360-0804 JAPAN

Tel

048-521-3133

Email

kantou@ps.ksky.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 01 Day


Related information

URL releasing protocol

https://www.mdpi.com/2077-0383/8/11/1911

Publication of results

Published


Result

URL related to results and publications

https://www.mdpi.com/2077-0383/8/11/1911

Number of participants that the trial has enrolled

16

Results

The one-year local control (LC) and overall survival rates were 81% and 71%, respectively.

Results date posted

2019 Year 12 Month 25 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 05 Day

Date of IRB

2018 Year 02 Month 05 Day

Anticipated trial start date

2018 Year 02 Month 05 Day

Last follow-up date

2019 Year 02 Month 06 Day

Date of closure to data entry

2019 Year 02 Month 06 Day

Date trial data considered complete

2019 Year 02 Month 06 Day

Date analysis concluded

2019 Year 02 Month 09 Day


Other

Other related information

1) diagnosed as recurrence from clinical course
2) evaluable lesions detected by CT or MRI
3) performance status 0 - 2
4) recurrence in the previous irradiation site


Management information

Registered date

2018 Year 02 Month 05 Day

Last modified on

2019 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035584


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name